[DEF 14A] John Wiley & Sons, Inc. Definitive Proxy Statement
John Wiley & Sons (WLYB) reports a year of operational improvement driven by Research and AI licensing while completing portfolio changes. On a non-GAAP basis, Wiley delivered $1.66 billion in Adjusted Revenue with a 24.0% Adjusted EBITDA margin and $126 million in Free Cash Flow. The company expanded adjusted operating margin by 300 basis points and increased share repurchases by 34% to $60 million.
From a GAAP perspective, full-year revenue was $1,678 million (down from $1,873 million) reflecting divestitures; operating income improved to $221 million (vs. $52 million prior) and diluted EPS was $1.53 (vs. a $3.65 loss). AI licensing revenue rose to $40 million from $23 million, and net debt to EBITDA was 1.8x. The Proxy sets the Annual Meeting for September 25, 2025 and asks shareholders to elect 10 directors, ratify PwC, and approve advisory executive compensation.
John Wiley & Sons (WLYB) presenta un anno di miglioramento operativo guidato dalle licenze nel settore Research e dell'IA, completando contestualmente cambi nel portafoglio. Su base non-GAAP, Wiley ha riportato $1,66 miliardi di Ricavi Rettificati con una margine EBITDA rettificato del 24,0% e $126 milioni di Free Cash Flow. L'azienda ha ampliato il margine operativo rettificato di 300 punti base e ha aumentato i riacquisti di azioni del 34% a $60 milioni.
Dal punto di vista GAAP, il fatturato annuo è stato di $1.678 milioni (in calo da $1.873 milioni) a seguito di dismissioni; l'utile operativo è salito a $221 milioni (vs. $52 milioni precedenti) e l'utile diluito per azione è stato di $1,53 (vs. perdita di $3,65). I ricavi da licenze legate all'IA sono aumentati a $40 milioni da $23 milioni, e il rapporto debito netto/EBITDA è stato di 1,8x. Il proxy fissa l'Assemblea annuale per il 25 settembre 2025 e chiede agli azionisti di eleggere 10 amministratori, ratificare PwC e approvare la remunerazione esecutiva in sede consultiva.
John Wiley & Sons (WLYB) presenta un año de mejora operativa impulsada por las licencias de Investigación y de IA, completando cambios en su cartera. Sobre una base non-GAAP, Wiley registró $1,66 mil millones de Ingresos Ajustados con un margen de EBITDA ajustado del 24,0% y $126 millones de Flujo de Caja Libre. La compañía amplió el margen operativo ajustado en 300 puntos básicos y aumentó las recompras de acciones un 34% hasta $60 millones.
Desde la perspectiva GAAP, los ingresos anuales fueron de $1.678 millones (desde $1.873 millones), reflejando desinversiones; el resultado operativo mejoró a $221 millones (vs. $52 millones antes) y la utilidad diluida por acción fue de $1,53 (vs. pérdida de $3,65). Los ingresos por licencias de IA subieron a $40 millones desde $23 millones, y la deuda neta/EBITDA fue de 1,8x. El proxy convoca la Junta Anual para el 25 de septiembre de 2025 y solicita a los accionistas elegir 10 directores, ratificar a PwC y aprobar la compensación ejecutiva en consulta.
John Wiley & Sons (WLYB)는 Research 및 AI 라이선스가 견인한 운영 개선의 해를 보내며 포트폴리오 변경을 완료했습니다. 비-GAAP 기준으로 Wiley는 $1.66 billion의 조정 매출(Adjusted Revenue)과 24.0%의 조정 EBITDA 마진, $126 million의 자유현금흐름(Free Cash Flow)을 기록했습니다. 회사는 조정 영업이익률을 300 베이시스 포인트 확대했고 자사주 매입을 34% 증가하여 $60 million으로 늘렸습니다.
GAAP 기준으로는 연간 매출이 $1,678 million으로(이전 $1,873 million 대비 감소) 매각 영향이 반영되었고, 영업이익은 $221 million으로 개선(이전 $52 million)되었으며 희석 주당순이익은 $1.53(이전에는 주당 손실 $3.65)이었습니다. AI 라이선스 수익은 $23 million에서 $40 million으로 증가했으며 순부채/EBITDA 비율은 1.8배였습니다. 프록시 문서는 연례 주주총회를 2025년 9월 25일로 지정하고, 주주들에게 10명의 이사 선임, PwC의 재선임 승인, 권고적 임원 보수안의 승인을 요청합니다.
John Wiley & Sons (WLYB) annonce une année d'amélioration opérationnelle portée par les licences en Research et IA, tout en finalisant des ajustements de portefeuille. Sur une base non-GAAP, Wiley a réalisé 1,66 milliard $ de chiffre d'affaires ajusté avec une marge d'EBITDA ajustée de 24,0% et 126 millions $ de flux de trésorerie disponible. La société a élargi sa marge opérationnelle ajustée de 300 points de base et a augmenté les rachats d'actions de 34% à 60 millions $.
Selon les normes GAAP, le chiffre d'affaires annuel s'est élevé à 1 678 millions $ (contre 1 873 millions $), en raison de cessions ; le résultat d'exploitation s'est amélioré à 221 millions $ (vs 52 millions $ auparavant) et le bénéfice dilué par action était de 1,53 $ (vs une perte de 3,65 $). Les revenus de licences IA sont passés de 23 millions $ à 40 millions $, et l'endettement net rapporté à l'EBITDA s'établit à 1,8x. Le proxy fixe l'assemblée générale annuelle au 25 septembre 2025 et demande aux actionnaires d'élire 10 administrateurs, de ratifier PwC et d'approuver la rémunération exécutive à titre consultatif.
John Wiley & Sons (WLYB) meldet ein Jahr operativer Verbesserungen, getrieben von Research- und KI-Lizenzgeschäften, und hat Portfolioänderungen abgeschlossen. Auf Non-GAAP-Basis erzielte Wiley $1,66 Milliarden bereinigten Umsatz mit einer bereinigten EBITDA-Marge von 24,0% und $126 Millionen Free Cash Flow. Das Unternehmen hat die bereinigte operative Marge um 300 Basispunkte ausgeweitet und die Aktienrückkäufe um 34% auf $60 Millionen erhöht.
Nach GAAP lagen die Jahreserlöse bei $1.678 Millionen (nach $1.873 Millionen), was Veräußerungen widerspiegelt; das Betriebsergebnis verbesserte sich auf $221 Millionen (vs. $52 Millionen zuvor) und das verwässerte Ergebnis je Aktie betrug $1,53 (vs. einen Verlust von $3,65). Die KI-Lizenzumsätze stiegen von $23 Millionen auf $40 Millionen, und die Nettoverschuldung zum EBITDA lag bei 1,8x. Die Proxy-Unterlagen legen die Hauptversammlung auf den 25. September 2025 und bitten die Aktionäre, 10 Direktoren zu wählen, PwC zu bestätigen und die beratende Vergütung der Geschäftsleitung zu genehmigen.
- Adjusted revenue of $1.66B with 24.0% adjusted EBITDA margin, showing underlying operating improvement
- GAAP operating income improved to $221M and diluted EPS rose to $1.53 from a prior-year loss
- AI licensing revenue increased to $40M (from $23M), expanding corporate market exposure
- Free Cash Flow of $126M and share repurchases increased 34% to $60M; dividend raised for the 31st consecutive year
- Board refreshment with two new directors adding AI, R&D, and technology expertise
- GAAP revenue declined to $1,678M (from $1,873M) due to foregone revenue from divested businesses
- Retail/channel softness in the Professional segment contributed to pressure offsetting some growth
- Net debt to EBITDA of 1.8x (up from 1.7x) indicates leverage that investors may monitor
- Company is a controlled company under NYSE rules, which may limit certain governance protections available to other public companies
- Forward-looking statements carry typical risks (technology investment, subscriber renewals, AI integration, cyber risk and other factors disclosed)
Insights
TL;DR Wiley delivered meaningful margin and cash-flow recovery, with AI licensing and cost reductions driving results.
Wiley's FY2025 performance shows a clear operational inflection: adjusted revenue of $1.66B and a 24.0% adjusted EBITDA margin reflect both top-line resilience in Research and Learning and sustained cost actions. The swing in GAAP operating income to $221M and diluted EPS of $1.53 from a prior-year loss signals reduced one-time charges and improved profitability. AI licensing growth to $40M demonstrates monetization of proprietary content and data for corporate customers, supporting higher-margin revenue streams. Capital allocation actions—$60M of buybacks and the 31st consecutive dividend increase—illustrate commitment to shareholder returns while maintaining leverage at 1.8x net debt/EBITDA.
TL;DR Board refreshment and governance practices are strong, though Wiley remains a controlled company with family voting influence.
The Board emphasizes independence with 8 of 10 directors independent and full independent membership of key committees (Audit, Compensation, Governance). Recent additions (Dr. Karen Madden and Katya Andresen) add R&D and AI/digital expertise aligned to strategic priorities. Governance practices—annual evaluations, orientation, clawback policies, and director retirement age—are documented and active. The Proxy also discloses controlled-company status under NYSE rules; the Board states it follows NYSE standards despite available exemptions, which is relevant for shareholders assessing oversight dynamics.
John Wiley & Sons (WLYB) presenta un anno di miglioramento operativo guidato dalle licenze nel settore Research e dell'IA, completando contestualmente cambi nel portafoglio. Su base non-GAAP, Wiley ha riportato $1,66 miliardi di Ricavi Rettificati con una margine EBITDA rettificato del 24,0% e $126 milioni di Free Cash Flow. L'azienda ha ampliato il margine operativo rettificato di 300 punti base e ha aumentato i riacquisti di azioni del 34% a $60 milioni.
Dal punto di vista GAAP, il fatturato annuo è stato di $1.678 milioni (in calo da $1.873 milioni) a seguito di dismissioni; l'utile operativo è salito a $221 milioni (vs. $52 milioni precedenti) e l'utile diluito per azione è stato di $1,53 (vs. perdita di $3,65). I ricavi da licenze legate all'IA sono aumentati a $40 milioni da $23 milioni, e il rapporto debito netto/EBITDA è stato di 1,8x. Il proxy fissa l'Assemblea annuale per il 25 settembre 2025 e chiede agli azionisti di eleggere 10 amministratori, ratificare PwC e approvare la remunerazione esecutiva in sede consultiva.
John Wiley & Sons (WLYB) presenta un año de mejora operativa impulsada por las licencias de Investigación y de IA, completando cambios en su cartera. Sobre una base non-GAAP, Wiley registró $1,66 mil millones de Ingresos Ajustados con un margen de EBITDA ajustado del 24,0% y $126 millones de Flujo de Caja Libre. La compañía amplió el margen operativo ajustado en 300 puntos básicos y aumentó las recompras de acciones un 34% hasta $60 millones.
Desde la perspectiva GAAP, los ingresos anuales fueron de $1.678 millones (desde $1.873 millones), reflejando desinversiones; el resultado operativo mejoró a $221 millones (vs. $52 millones antes) y la utilidad diluida por acción fue de $1,53 (vs. pérdida de $3,65). Los ingresos por licencias de IA subieron a $40 millones desde $23 millones, y la deuda neta/EBITDA fue de 1,8x. El proxy convoca la Junta Anual para el 25 de septiembre de 2025 y solicita a los accionistas elegir 10 directores, ratificar a PwC y aprobar la compensación ejecutiva en consulta.
John Wiley & Sons (WLYB)는 Research 및 AI 라이선스가 견인한 운영 개선의 해를 보내며 포트폴리오 변경을 완료했습니다. 비-GAAP 기준으로 Wiley는 $1.66 billion의 조정 매출(Adjusted Revenue)과 24.0%의 조정 EBITDA 마진, $126 million의 자유현금흐름(Free Cash Flow)을 기록했습니다. 회사는 조정 영업이익률을 300 베이시스 포인트 확대했고 자사주 매입을 34% 증가하여 $60 million으로 늘렸습니다.
GAAP 기준으로는 연간 매출이 $1,678 million으로(이전 $1,873 million 대비 감소) 매각 영향이 반영되었고, 영업이익은 $221 million으로 개선(이전 $52 million)되었으며 희석 주당순이익은 $1.53(이전에는 주당 손실 $3.65)이었습니다. AI 라이선스 수익은 $23 million에서 $40 million으로 증가했으며 순부채/EBITDA 비율은 1.8배였습니다. 프록시 문서는 연례 주주총회를 2025년 9월 25일로 지정하고, 주주들에게 10명의 이사 선임, PwC의 재선임 승인, 권고적 임원 보수안의 승인을 요청합니다.
John Wiley & Sons (WLYB) annonce une année d'amélioration opérationnelle portée par les licences en Research et IA, tout en finalisant des ajustements de portefeuille. Sur une base non-GAAP, Wiley a réalisé 1,66 milliard $ de chiffre d'affaires ajusté avec une marge d'EBITDA ajustée de 24,0% et 126 millions $ de flux de trésorerie disponible. La société a élargi sa marge opérationnelle ajustée de 300 points de base et a augmenté les rachats d'actions de 34% à 60 millions $.
Selon les normes GAAP, le chiffre d'affaires annuel s'est élevé à 1 678 millions $ (contre 1 873 millions $), en raison de cessions ; le résultat d'exploitation s'est amélioré à 221 millions $ (vs 52 millions $ auparavant) et le bénéfice dilué par action était de 1,53 $ (vs une perte de 3,65 $). Les revenus de licences IA sont passés de 23 millions $ à 40 millions $, et l'endettement net rapporté à l'EBITDA s'établit à 1,8x. Le proxy fixe l'assemblée générale annuelle au 25 septembre 2025 et demande aux actionnaires d'élire 10 administrateurs, de ratifier PwC et d'approuver la rémunération exécutive à titre consultatif.
John Wiley & Sons (WLYB) meldet ein Jahr operativer Verbesserungen, getrieben von Research- und KI-Lizenzgeschäften, und hat Portfolioänderungen abgeschlossen. Auf Non-GAAP-Basis erzielte Wiley $1,66 Milliarden bereinigten Umsatz mit einer bereinigten EBITDA-Marge von 24,0% und $126 Millionen Free Cash Flow. Das Unternehmen hat die bereinigte operative Marge um 300 Basispunkte ausgeweitet und die Aktienrückkäufe um 34% auf $60 Millionen erhöht.
Nach GAAP lagen die Jahreserlöse bei $1.678 Millionen (nach $1.873 Millionen), was Veräußerungen widerspiegelt; das Betriebsergebnis verbesserte sich auf $221 Millionen (vs. $52 Millionen zuvor) und das verwässerte Ergebnis je Aktie betrug $1,53 (vs. einen Verlust von $3,65). Die KI-Lizenzumsätze stiegen von $23 Millionen auf $40 Millionen, und die Nettoverschuldung zum EBITDA lag bei 1,8x. Die Proxy-Unterlagen legen die Hauptversammlung auf den 25. September 2025 und bitten die Aktionäre, 10 Direktoren zu wählen, PwC zu bestätigen und die beratende Vergütung der Geschäftsleitung zu genehmigen.
☐ | Preliminary Proxy Statement |
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☒ | Definitive Proxy Statement |
☐ | Definitive Additional Materials |
☐ | Soliciting Material Pursuant to §240.14a-12 |
☒ | No fee required. | |||
☐ | Fee paid previously with preliminary materials. | |||
☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |

A message from our Board Chair |

Best wishes, | ||
![]() | ||
Jesse C. Wiley Chair, Wiley Board of Directors |
A message from our President and Chief Executive Officer |

![]() | |
Matthew S. Kissner President and CEO |

Notice of Annual Meeting of Shareholders |
Date and Time | Advanced Voting Methods | |
The 2025 Annual Meeting will be held on Thursday, September 25, 2025, at 8:00 A.M. EDT. Location The 2025 Annual Meeting of Shareholders of John Wiley & Sons, Inc. will be held online at www.virtualshareholdermeeting.com/ WLY2025 | Internet: You will need the 16-digit number included in your proxy card, voting instruction form or notice – Vote by visiting www.proxyvote.com | |
Telephone: Call the phone number located on your proxy card or voting instruction form | ||
Mail: Complete, sign, date and return your proxy card or voting instruction form in the envelope provided |
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Shareholders to be held on September 25, 2025. Our Notice of Annual Meeting, Proxy Statement and Annual Report for the fiscal year ended April 30, 2025, are available at www.proxyvote.com. We are making the Proxy Statement and the form of proxy first available on or about August 14, 2025. |
Proxy Statement Summary | 1 |
Matters to be voted on at our 2025 Annual Meeting of Shareholders | 1 |
About Wiley in Fiscal Year 2025 | 2 |
Fiscal Year 2025 Business Overview | 3 |
Corporate Governance Highlights | 4 |
Director Skills and Experience | 5 |
Director Highlights | 7 |
Proposal 1. Election of Directors | 8 |
Director Nominees | 8 |
Director Biographies | 9 |
Corporate Governance | 19 |
Our Board of Directors | 19 |
Board Composition and Refreshment | 19 |
Attendance | 20 |
Director Independence | 21 |
Board Leadership Structure | 21 |
Director Orientation and Continuing Education | 22 |
Board and Committee Assessments | 22 |
Shareholder Recommendations and Nominations of Director Candidates | 23 |
Key Corporate Governance Documents | 23 |
Business Conduct and Code of Ethics | 23 |
Corporate Governance Principles | 24 |
Insider Trading Policy | 24 |
Executive Compensation Clawback Policy | 24 |
Transactions with Related Persons | 25 |
Committees of the Board of Directors | 26 |
The Board's Oversight of Risk Management | 32 |
Director Compensation | 37 |
Highlights of our Director Compensation Program | 37 |
Director Compensation Table | 39 |
Outstanding Deferred Stock Awards at Fiscal Year End | 40 |
Non-Management Stock Ownership Guidelines | 40 |
Communications with the Board | 41 |
ESG and Corporate Impact | 42 |
Environmental Responsibility | 42 |
Inclusion and Belonging | 42 |
Publishing Ethics and Integrity | 43 |
Audit Committee Matters | 45 |
Audit Committee Report | 45 |
Proposal 2. Ratification of Appointment of Independent Registered Public Accounting Firm | 47 |
Audit Committee Fees | 48 |
Proposal 3. Non-Binding Advisory Vote of Named Executive Officer Compensation | 49 |
Executive Compensation | 50 |
Compensation Discussion and Analysis | 50 |
A message from the Executive Compensation and Development Committee Chair | 50 |
Fiscal Year 2025 Named Executive Officers | 51 |
Compensation Highlights | 52 |
Compensation Snapshot – CEO and NEOs | 52 |
Our Compensation Governance Best Practices | 53 |
Equity Grant Timing Practices | 54 |
How We Make Compensation Decisions | 54 |
Summary Compensation Table | 64 |
Grants of Plan-Based Awards | 66 |
Outstanding Equity Awards at Fiscal Year End | 68 |
Option Exercises and Stock Vested | 69 |
Non-Qualified Deferred Compensation | 70 |
Potential Payments Upon Termination or Change in Control | 71 |
Compensation Committee Report | 77 |
CEO Pay Ratio | 78 |
Identification of Median Employee | 78 |
Annual Total Compensation | 78 |
Pay Versus Performance Disclosure | 79 |
Ownership of Common Stock | 83 |
Stock Ownership of Officers and Directors | 83 |
Stock Ownership of Certain Beneficial Owners | 85 |
Delinquent Section 16(a) Reports | 87 |
Information about the Annual Meeting | 88 |
Voting Procedures | 88 |
Attending the Annual Meeting | 91 |
2025 Proxy Materials | 91 |
Other Matters | 93 |
Shareholder Proposals and Director Nominations for the 2026 Annual Shareholder Meeting | 93 |
2025 Proxy Statement | ![]() | 1 |
Proposal | Description | Board's Recommendation | Page |
1 | Election of 10 Director Nominees | FOR each Nominee | 8 |
2 | Ratification of the appointment by the Board of Directors of PricewaterhouseCoopers LLP as the Company’s independent public accountants for the fiscal year ending April 30, 2026 (Ratification Proposal) | FOR | 47 |
3 | Approve, on an advisory basis, the compensation of our named executive officers (Say-On-Pay Proposal) | FOR | 49 |
![]() | ![]() | ![]() | ![]() | |||
INTERNET | SCAN | PHONE | MAIL | |||
Locate the 16-digit control number included in your proxy card, voting instruction form or notice in order to access the website indicated. | Your proxy card, voting instruction form or notice may also include a QR code for voting by your mobile phone. | You may submit your proxy by touch-tone telephone by dialing the number indicated on your proxy card or voting instruction form. You will need the 16- digit control number shown on your proxy card or voting instruction form. | Mark, sign and date your proxy card or voting instruction form and return it in the postage-paid envelope provided. | |||
2 | ![]() | 2025 Proxy Statement |
Proxy Statement Summary |




2025 Proxy Statement | ![]() | 3 |
Proxy Statement Summary |

300 basis points |
Adjusted Operating Margin expansion |
+34% |
Increase in share repurchases |
$40M |
Total AI Licensing Revenue (vs $23M in FY 2024) |
31st |
Consecutive year dividend raised |
4 | ![]() | 2025 Proxy Statement |
Proxy Statement Summary |
Independence | |
■8 of 10 current directors are independent ■Audit, Executive Compensation and Development (the "ECDC" or "Compensation Committee") and Governance Committees are comprised 100% of independent directors ■Regular executive sessions of non-management directors, of independent directors chaired by the Chair of the Governance Committee, and committees chaired by independent committee chairs ■Director access to internal and external expert advisors ■Separate Board Chair and Chief Executive Officer ("CEO") roles | |
Board Refreshment, Development and Succession Planning | |
■Comprehensive Board succession outlook and planning process ■Focus and commitment to actively seek out highly qualified candidates, including women, underrepresented groups, and candidates with diverse backgrounds, skills and experiences, to include in the pool from which Board nominees are chosen. ■Annual Board and Committee self-evaluations and periodic individual director evaluations ■Continual review of Board composition, considering skills, experience and attributes of existing directors, individually and as a group ■Regular Board refreshment and mix of tenure of directors ■Director retirement age of 75 ■Comprehensive director orientation and ongoing director education program ■Annual election of all Board directors | |
Compensation Governance | |
■Performance-based compensation and incentive payments based on financial results relative to pre- established targets ■Rigorous director and executive stock ownership requirements ■Appropriate director compensation structured in a manner that is aligned with shareholder interests ■Prohibit pledging, hedging, short sales, and derivative transactions by directors, officers and colleagues ■Stringent clawback policy ■No related party transactions | |
Risk Management | |
■Board and committees take an active role in the Company’s strategy, risk oversight and risk management processes, including active oversight of Environmental, Social & Governance ("ESG"), and human capital management ■Board oversight of cybersecurity risks, policies, controls and procedures | |
Other Board Best Practices | |
■Global Code of Conduct applicable to directors and all colleagues that includes an annual certification requirement ■Strong director meeting attendance ■Monitoring of outside board service levels ■Board and Compensation Committee annually engage in comprehensive senior management succession planning ■Oversight of our human capital talent development, inclusion and belonging, and corporate culture initiatives by the ECDC, including regular talent reviews ■Consistent periodic review of emergency and non-emergency CEO succession |
2025 Proxy Statement | ![]() | 5 |
Proxy Statement Summary |
Kissner | Wiley | Andresen | Baker | Dobson | Hemphill | Madden | McDaniel | Pesce | Singh | ||
Public Company Areas of Experience | |||||||||||
![]() | Accounting/Finance | ![]() | • | • | • | • | ![]() | • | ![]() | ||
![]() | Corporate Governance | • | ![]() | • | • | • | ![]() | ![]() | • | ||
![]() | Leadership | ![]() | • | • | ![]() | ![]() | • | ![]() | ![]() | ![]() | ![]() |
![]() | Talent Strategy and Organizational Development | • | • | ![]() | • | • | • | • | ![]() | • | |
![]() | Mergers and Acquisitions | • | • | • | • | • | • | • | ![]() | ![]() | ![]() |
![]() | Risk Management | • | • | • | • | • | • | • | • | ![]() | |
![]() | Strategic Development | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
![]() | Technology | • | ![]() | • | ![]() | • | ![]() | • | ![]() | ||
Strategic Areas of Experience | |||||||||||
![]() | Sales and Go-To-Market | ![]() | ![]() | • | ![]() | • | |||||
![]() | Digital Marketing/E- commerce | ![]() | • | ![]() | • | ||||||
![]() | Digital Product Management | ![]() | ![]() | • | • | • | |||||
![]() | International Experience | ![]() | ![]() | • | • | • | • | • | • | • | |
![]() | Innovation/Transformation | ![]() | ![]() | ![]() | • | ![]() | ![]() | • | • | • | |
![]() | Academic or Corporate R&D Leadership | • | ![]() | ![]() | • | • |

6 | ![]() | 2025 Proxy Statement |
Proxy Statement Summary |
![]() | Accounting/Finance | Experience managing a company’s financial health, including budgeting, forecasting, accounting and/or financial reporting, leveraging technology to improve a company’s financial systems and controls, the ability to prepare and understand fundamental financial statements, and/or serving as an audit committee member of a publicly traded company. |
![]() | Corporate Governance | Service on the boards and board committees of other public companies or large private companies, including an understanding of corporate governance practices and trends, insights into board management, relations between the board, the CEO, and senior management, applicable regulations, institutional investors, and succession planning or an executive position responsible for board relations. |
![]() | Leadership | Executive management experience leading a business unit, engaging directly with stakeholders, including customers, employees and investors, and operating a complex organization such as a medium to large corporation or organization. |
![]() | Talent Strategy and Organizational Development | Oversight responsibility or experience leading or overseeing an HR function, including leadership development, CEO succession, talent development and retention, inclusion and belonging, compensation plans, performance management, the future of work and culture development. |
![]() | Mergers and Acquisitions | Oversight responsibility or experience in a leadership role directly involved in mergers, acquisitions, divestitures, and partnerships, including due diligence, integration and divestment. |
![]() | Risk Management | Expertise and/or experience in identifying, managing, and mitigating risks and developing/ implementing enterprise risk management. |
![]() | Strategic Development | Oversight responsibility or experience leading and/or actively participating in the development and execution of strategic plans including operationalizing and monitoring KPI’s and leading indicators. |
![]() | Technology | Oversight responsibility or experience developing/implementing technology solutions and systems, managing the development of software products and data services, SaaS, and/or analytics, including use of Artificial Intelligence, and/or a strong understanding of emerging technologies and trends. |
![]() | Sales and Go-To-Market | Oversight responsibility or experience leading customer-facing teams including sales, business partner and development, developing pipelines and relationships that build brand value, leading market development strategies and plans, expanding sales in existing and new markets, customer service and account management, including B2C and B2B. |
![]() | Digital Marketing/E- commerce | Oversight responsibility or experience in a leadership role with responsibility for marketing, including the latest digital tools and channels, customer experience and data, user experience, and/or eCommerce, including B2C and B2B. |
![]() | Digital Product Management | Oversight responsibility or experience in a leadership role with responsibility for digital product management, innovating customer centric software platforms, data services, especially in information services, life sciences, or media industries that leverage customer and content data, including IP rights and management. |
![]() | International Experience | Oversight responsibility or experience leading a division/business unit of a multinational corporation in countries such as China, India and Western Europe. |
![]() | Innovation/ Transformation | Oversight responsibility or significant experience leading strategic transformation or managing change and disruption by driving innovation in an organization needing to evolve with customers, leveraging new tools and technologies, like Generative AI (GenAI), and new business models. |
![]() | Academic or Corporate R&D Leadership | Oversight responsibility or senior leadership of an academic, government or research funded institution, or a corporate Research & Development ("R&D") unit or company, or experience leading research, development and innovation initiatives, including R&D investment, intellectual property, and commercialization. Senior management or leadership of an R1 institution, ideally active in STEM fields. |
2025 Proxy Statement | ![]() | 7 |
Proxy Statement Summary |
62.4 |
Average age |
8.7 years |
Average tenure |
8 out of 10 |
Directors are independent |




Kissner | Wiley | Andresen | Baker | Dobson | Hemphill | Madden | McDaniel | Pesce | Singh | ||
Director Demographics | |||||||||||
Year Appointed | 2025 | 2012 | 2025 | 2011 | 2017 | 2022 | 2025 | 2005 | 1998 | 2021 | |
Tenure | 2* | 12 | <1 | 13 | 8 | 3 | <1 | 19 | 27 | 3 | |
Independent | • | • | • | • | • | • | • | • | |||
Age | 71 | 55 | 57 | 60 | 63 | 55 | 56 | 67 | 74 | 66 | |
Gender | M | M | F | F | M | M | F | M | M | M | |
Asian | • | ||||||||||
Black | • | ||||||||||
White | • | • | • | • | • | • | • | • |
8 | ![]() | 2025 Proxy Statement |
2025 Proxy Statement | ![]() | 9 |
Proposal No. 1 - Election of Directors |
Katya D. Andresen | Ms. Andresen brings over 25 years of experience driving digital transformation and technology innovation across diverse industries. She is a recognized expert in artificial intelligence, data monetization, and enterprise-wide digital strategy, having held senior executive positions in Fortune 500 companies focused on leveraging technology to create new business models and drive customer experience innovation. Since 2021, she has served as Chief Digital and Analytics Officer at The Cigna Group, where she leads digital transformation initiatives across the $247 billion global health services company. Her expertise spans building AI-powered solutions, transforming traditional businesses into digital-first organizations, and scaling technology capabilities across large, complex enterprises. She actively contributes to the venture capital ecosystem, academic communities, and mission- driven organizations in various capacities, including as a Wiley- published author and thought leader on digital innovation. Ms. Andresen currently serves on the boards of Forsyth Health and the Morrison Center for Marketing and Analytics at the UCLA Anderson School of Management and is a sought-after AI advisor to venture capital firms. | |
![]() | ||
Age: 57 Director Since: 2025 Wiley Committees: ▪None | Current Outside Directorships: ▪Morrison Center for Marketing and Analytics at the UCLA Anderson School of Management ▪Forsyth Health | Former Directorships Held During the Past Five Years: ▪None |
Skills & Qualifications: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() The Board believes Ms. Andresen brings the requisite experience in digital transformation and artificial intelligence leadership to the Board, with over 25 years of expertise directly aligned with Wiley's strategic priorities in AI integration, digital-first subscription models, and technology-enabled innovation. Her specialization in AI-powered solutions, data monetization, and enterprise-wide digital strategy provides critical insight for transforming traditional academic publishing into scalable digital platforms, while her experience building technology capabilities across large, complex organizations directly supports Wiley's evolution in serving the global research community through advanced digital tools and safeguards. | ||
10 | ![]() | 2025 Proxy Statement |
Proposal No. 1 - Election of Directors |
Brian O. Hemphill | Dr. Hemphill has extensive executive leadership experience in academia, bringing insight into the needs and practices of the academic community critical for developing and innovating new business models in our key businesses. Dr. Hemphill has served as Old Dominion University's (ODU) ninth president since 2021 and previously served as Radford University's seventh president from 2016 to 2021. Dr. Hemphill has also held senior roles at various educational institutions earlier in his career, including the University of Arkansas- Fayetteville, Northern Illinois University, and West Virginia State University. In his role as President of ODU, Dr. Hemphill serves on various boards and commissions. He also serves on the boards of Jefferson Science Associates, LLC and Preston Hollow Community Capital. | |
![]() | ||
Age: 55 Director Since: 2022 Wiley Committees: ▪Governance Committee (Chair) ▪Executive Committee | Current Outside Directorships: ▪Greater Norfolk Corporation ▪Hampton Roads Maritime Collaborative for Growth & Innovation ▪Hampton Roads Biomedical Research Consortium ▪Hampton Roads Chamber of Commerce ▪Jefferson Science Associates, LLC ▪ODU Board of Trustees: Educational Foundation, Research Foundation, Athletic Foundation, and Real Estate ▪Preston Hollow Community Capital ▪Sunbelt Conference | Former Directorships Held During the Past Five Years: ▪American Association of State Colleges and Universities (AASCU) (2023) ▪Carilion New River Valley Medical Center (2021) ▪Genedge (2022) ▪Roanoke Higher Education Center (2021) ▪Southwest Virginia Higher Education Center (2021) ▪The Lebron James Family Foundation I Promise Institute Bureau (2023) |
Skills & Qualifications: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() The Board believes Dr. Hemphill brings the requisite experience in academic leadership and R&D institution management to the Board, providing invaluable insight into the evolving needs of universities and research institutions that comprise Wiley's core customer base. His executive leadership in higher education demonstrates deep understanding of academic publishing requirements, research funding dynamics, and the digital transformation challenges facing educational institutions, while his governance experience across multiple boards provides the strategic oversight needed to guide Wiley's continued innovation in serving the academic and scientific research communities. |
2025 Proxy Statement | ![]() | 11 |
Proposal No. 1 - Election of Directors |
Karen N. Madden | Dr. Madden has extensive executive leadership experience in life science technology and innovation, bringing strategic vision to research and development in the pharmaceutical and biotech industries. Dr. Madden has served as Senior Vice President and Chief Technology Officer at MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany since 2022. Previously, Dr. Madden served as Senior Vice President and Chief Innovation Officer at PerkinElmer from 2016 to 2022, and as their General Manager of Informatics from 2014 to 2016. In her role at MilliporeSigma, Dr. Madden shapes the Technology Roadmap and long-term R&D strategy, leads the Life Science Innovation Board, and serves as a member of the Life Science Executive Team responsible for the overall leadership and governance of the more than $9 billion Life Science Business. She also serves as the U.S. Country Speaker for Merck KGaA, Darmstadt, Germany, and sits on the boards of the Analytical, Life Science, and Diagnostics Association, and the New England Council. | |
![]() | ||
Age: 56 Director Since: 2025 Wiley Committees: ▪Audit Committee | Current Outside Directorships: ▪Analytical, Life Science & Diagnostics Association ▪New England Council | Former Directorships Held During the Past Five Years: ▪None |
Skills & Qualifications: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() The Board believes Dr. Madden brings the requisite experience in life science technology and corporate R&D leadership to the Board, with strategic innovation expertise that directly supports Wiley's scientific journal publishing and academic research initiatives. Her role shaping technology roadmaps and leading R&D strategy across a multi-billion dollar life science business provides critical insight into the research and development priorities of Wiley's scientific publishing customers, while her deep understanding of intellectual property, commercialization, and research innovation processes enhances Wiley's ability to develop products and services that advance scientific discovery and knowledge dissemination. |
The Board recommends a vote "FOR" the election of all Director Nominees. |
12 | ![]() | 2025 Proxy Statement |
Proposal No. 1 - Election of Directors |
Mari J. Baker | Ms. Baker has over 20 years of board service in public, private and non-profit environments. She is an experienced general manager and business leader, and has held a number of executive officer positions in public and private companies primarily in technology fields, including roles as Chief Executive Officer of PlayFirst, Inc. and Navigenics, Inc., Chief Operating Officer of Velti, plc (Nasdaq: VELT), President of BabyCenter, Inc., a Johnson and Johnson company (NYSE: JNJ), and SVP/General Manager at Intuit, Inc. (Nasdaq: INTU). She has also been involved in venture capital, higher education, and executive leadership communities, in various capacities, including serving on the Board of Trustees of Stanford University. Ms. Baker also currently serves on the board of Blue Shield of California, where she chairs the Audit Committee. | |
![]() | ||
Age: 60 Director Since: 2011 Wiley Committees: ▪Executive Compensation and Development Committee (Chair) ▪Executive Committee | Current Outside Directorships: ▪Blue Shield of California | Former Directorships Held During the Past Five Years: ▪Healthline, Inc. (2020) ▪GoShip, Inc. (2023) ▪Quicken, Inc. (2021) |
Skills & Qualifications: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() The Board believes Ms. Baker brings the requisite experience in executive leadership and corporate governance to the Board, with her proven track record guiding technology-driven organizations through strategic transformation and complex stakeholder management. Her experience as CEO of multiple companies demonstrates the leadership capabilities essential for navigating Wiley's expansion into new market segments, while her extensive board governance experience and current audit committee leadership provide the oversight expertise critical for ensuring strong corporate governance practices as Wiley continues its digital transformation and international growth initiatives. |
2025 Proxy Statement | ![]() | 13 |
Proposal No. 1 - Election of Directors |
David C. Dobson | Mr. Dobson has over 30 years of experience in transforming and building global technology and service organizations as well as extensive experience in senior leadership positions. Mr. Dobson has been Chief Executive Officer of Epiq, a global provider of legal and business services, since 2019, and also serves on its board of directors. Previously, Mr. Dobson was the Chief Executive Officer of Digital River from 2013 to 2018 and served as Vice Chairman of the Digital River's Board of Directors until 2019. From 2010 to 2012, Mr. Dobson served as Executive Vice President and Group Executive, Global Lines of Business, at CA Technologies. From 2009 to 2010, Mr. Dobson served as President of Pitney Bowes Management Services, Inc., a wholly owned subsidiary of Pitney Bowes, Inc. | |
![]() | ||
Age: 63 Director Since: 2017 Wiley Committees: ▪Executive Compensation and Development Committee ▪Governance Committee | Current Outside Directorships: ▪Epiq | Former Directorships Held During the Past Five Years: ▪Versapay (2020) |
Skills & Qualifications: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() The Board believes Mr. Dobson brings the requisite experience in global technology transformation and service organization leadership to the Board, with over 30 years of expertise in building platforms that serve professional communities. His demonstrated ability to transform traditional service businesses into technology-enabled organizations directly aligns with Wiley's mission to innovate academic publishing and scientific journal delivery, while his experience scaling global operations provides the strategic vision needed to expand Wiley's reach in serving research institutions and professional societies worldwide. |
14 | ![]() | 2025 Proxy Statement |
Proposal No. 1 - Election of Directors |
Matthew S. Kissner | Mr. Kissner was appointed the President and CEO of the Company effective July 8, 2024. Prior to Mr. Kissner's appointment, he served as interim President and CEO from October 2023 to July 2024 and as Director since October 2023. He also served as a Group Executive at the Company from 2019 through 2021 and provided transition and subsequently consulting services from 2021 to immediately prior to his appointment as interim CEO in October 2023. Mr. Kissner also was a director of the Company from 2003 to 2019, serving as the first non- Wiley family member as Chair from 2015 to 2019. He also served as an interim President and CEO of Wiley from May 2017 to December 2017. Mr. Kissner is a former Executive Vice President and Group President of Pitney Bowes and has held leadership positions at Banker's Trust, Citigroup, and Morgan Stanley. Additionally, Mr. Kissner has been an Operating Partner working with Private Equity Firms, where he served as an Executive Chairman and a Director of a number of businesses. | |
![]() | ||
Age: 71 Director Since: 2003-2019; 2023 Wiley Committees: ▪None | Current Outside Directorships: ▪Regional Plan Association | Former Directorships Held During the Past Five Years: ▪None |
Skills & Qualifications: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() The Board believes Mr. Kissner brings the requisite experience in executive leadership and strategic transformation to the Board, having successfully guided Wiley through critical transitions while demonstrating deep expertise in mergers and acquisitions and organizational development. His extensive background leading complex transformation initiatives, combined with his experience in private equity and strategic investment evaluations, provides the operational expertise needed to execute Wiley's digital transformation strategy, while his proven ability to drive innovation and change management ensures effective leadership of initiatives in AI integration, new market development, and evolving customer engagement models. |
2025 Proxy Statement | ![]() | 15 |
Proposal No. 1 - Election of Directors |
Raymond W. McDaniel, Jr. | ||
Mr. McDaniel is a seasoned non-executive director, having served as the non-executive Chair of the Board of Directors of Moody's Corporation from 2021 to 2023 and Chair from 2005 to 2012 and a member of the board from 2003 to 2023. Mr. McDaniel is also a global leader with extensive strategic and operational knowledge in a highly regulated financial services environment and experienced in implementing international business expansion, including the launch of new products. He previously served as the Chief Executive Officer of Moody's Corporation for over 15 years from 2005 through 2020 as well as held additional roles in senior leadership, including as President and Chief Operating Officer of Moody's Corporation. Mr. McDaniel serves on the board of directors of Raymond James Financial (NYSE: RJF) and as a Trustee on the Muhlenberg College Board. | ||
![]() | ||
Age: 67 Director Since: 2005 Wiley Committees: ▪Executive Committee (Chair) ▪Audit Committee | Current Outside Directorships: ▪Muhlenberg College ▪Raymond James Financial (NYSE: RJF) | Former Directorships Held During the Past Five Years: ▪Moody's Corporation (2023) (NYSE: MCO) |
Skills & Qualifications: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() The Board believes Mr. McDaniel brings the requisite experience in executive leadership and international business expansion to the Board, with extensive expertise navigating complex regulatory environments and implementing global growth strategies. His proven capabilities in financial services and strategic transformation in highly regulated industries provide valuable perspective for Wiley's expansion into new geographic markets and development of innovative subscription models, while his experience guiding organizations through strategic planning and international expansion directly supports Wiley's strategic priorities in global market development and regulatory compliance. |
16 | ![]() | 2025 Proxy Statement |
Proposal No. 1 - Election of Directors |
William J. Pesce | Mr. Pesce has extensive experience with leading a global public company, strategic planning, financial planning and analysis, acquisitions and partnerships, and investor relations. In addition, through his active engagement in the academic community and investing in early-stage companies, he has exposure to innovative, technology-enabled business models. He served as Wiley's 10th President and Chief Executive Officer for 13 years from 1998 to 2011, when he retired after nearly 22 years. Mr. Pesce is a member of the Board of Trustees of William Paterson University. Mr. Pesce is also a benefactor and advisor to the Pesce Family Mentoring Institute at William Paterson University. He served on the Board of Overseers of New York University's Stern School of Business for 17 years until 2005. Mr. Pesce also launched Pesce Family Ventures, LLC in 2015 with the aim to invest in early-stage companies, particularly entities that leverage enabling technology to serve customers. | |
![]() | ||
Age: 74 Director Since: 1998 Wiley Committees: ▪Executive Compensation & Development Committee ▪Governance Committee | Current Outside Directorships: ▪William Paterson University ▪Pesce Family Ventures, LLC | Former Directorships Held During the Past Five Years: ▪None |
Skills & Qualifications: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() The Board believes Mr. Pesce provides the requisite experience in executive leadership, corporate governance and strategic business development, as well as an in-depth knowledge of Wiley's evolution over multiple decades. His invaluable insights reflect a deep understanding of Wiley's markets and business; his active engagement with the academic community, including institutional leadership, faculty, researchers and students; and his investments in entrepreneurial technology-enabled companies. His extensive experience as Wiley's former CEO combined with his active involvement with the academic community and current investments in innovative, early-stage companies provide a unique and highly relevant perspective regarding Wiley's evolution as a global enterprise. |
2025 Proxy Statement | ![]() | 17 |
Proposal No. 1 - Election of Directors |
Inder M. Singh | Mr. Singh has extensive finance and corporate management experience, as well as knowledge in the technology and infrastructure sectors in both developed and emerging markets, having served as Executive Vice President and Chief Financial Officer of Arm Limited from 2019 to 2022. From 2016 to 2019, Mr. Singh served as Senior Vice President and Chief Financial Officer, and in 2016, as Chief Strategy and Marketing Officer, of Unisys Corp. Prior to that, Mr. Singh was a Managing Director at SunTrust Bank's equities unit from 2013 to 2016, and a Senior Vice President in finance at Comcast Corporation from 2012 to 2013. Mr. Singh is currently a member of the Board of Directors of IonQ (NYSE: IONQ), Axelera AI, ICEYE, and the advisory board of Resonance. He is the Chair of the Audit Committees at IonQ, Axelera, ICEYE, and Wiley. He has advised startups as a member of Columbia University's Entrepreneurship Advisory Board and Engineering Development Council. He has also participated as a project advisor for the U.S. Department of Homeland Security and other agencies on national security and critical infrastructure matters. | |
![]() | ||
Age: 66 Director Since: 2021 Wiley Committees: ▪Audit Committee (Chair) ▪Executive Committee | Current Outside Directorships: ▪Axelera AI ▪IonQ (NYSE: IONQ) ▪ICEYE ▪Resonance | Former Directorships Held During the Past Five Years: ▪Affinity Federal Credit Union |
Skills & Qualifications: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() The Board believes Mr. Singh brings the requisite experience in finance, accounting, and technology sector management to the Board, providing the financial expertise and risk management capabilities essential for Wiley's strategic transformation initiatives. His experience as CFO of complex technology organizations demonstrates the financial acumen needed to evaluate and execute mergers and acquisitions, optimize subscription model economics, and manage the financial aspects of digital transformation, while his current audit committee leadership across multiple technology companies provides the governance and risk oversight expertise critical for ensuring strong financial controls and strategic investment decisions. |
18 | ![]() | 2025 Proxy Statement |
Proposal No. 1 - Election of Directors |
Jesse C. Wiley | Mr. Wiley is a 7th generation member of the Wiley family and brings to the Board deep knowledge and a passion for the contributions Wiley makes to research, learning and knowledge. His alignment with shareholder and stakeholder interests makes Mr. Wiley an important part of the Board’s governance processes along with a majority of independent directors. Mr. Wiley has broad and deep experience in Wiley's industries with partners and customers in the markets Wiley serves. He also brings in-depth knowledge of numerous businesses, functions and initiatives within Wiley, including in digital publishing and platforms, new product and business development, partnerships and global business and M&A. Mr. Wiley was elected Chair of the Board of Directors of Wiley in 2019, having served as a director since 2012. Prior to being elected as Chair, Mr. Wiley had been an employee since 2003. Before becoming Chair, Mr. Wiley worked in Wiley's Research division on business development, including building partnerships with academic and professional societies, and in China. Previously he worked in corporate M&A and strategy development, international business development, digital and new business initiatives, and product development. Prior to that, he worked as a marketer and editor of professional books and products. | |
![]() | ||
Age: 55 Director Since: 2012 Chair of the Board Since: 2019 Wiley Committees: ▪Executive Committee | Current Outside Directorships: ▪None | Former Directorships Held During the Past Five Years: ▪None |
Skills & Qualifications: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() The Board believes Mr. Wiley brings the requisite experience in comprehensive business leadership and deep institutional knowledge to the Board with extensive operational expertise across all core areas of the Company's business. His unique combination of hands-on experience spanning research publishing, digital platform development, corporate strategy, and partnership development with academic societies provides unparalleled insight into every facet of Wiley's operations and strategic opportunities. As both a long-term stakeholder representing the founding family's vision and an experienced leader who has worked across multiple divisions since 2003, Mr. Wiley ensures continuity of Wiley's mission to advance research, learning, and knowledge while bringing practical understanding of the operational challenges and opportunities facing each business segment in today's rapidly evolving academic publishing landscape. |
The Board recommends a vote "FOR" the election of all Director Nominees. |
2025 Proxy Statement | ![]() | 19 |
20 | ![]() | 2025 Proxy Statement |
Corporate Governance |
2025 Proxy Statement | ![]() | 21 |
Corporate Governance |
22 | ![]() | 2025 Proxy Statement |
Corporate Governance |
2025 Proxy Statement | ![]() | 23 |
Corporate Governance |
24 | ![]() | 2025 Proxy Statement |
Corporate Governance |
2025 Proxy Statement | ![]() | 25 |
Corporate Governance |
26 | ![]() | 2025 Proxy Statement |
Corporate Governance |
2025 Proxy Statement | ![]() | 27 |
Corporate Governance |
Committees of the Board | |||||
Director | Board3 | Audit | Compensation | Executive | Governance4 |
Matthew S. Kissner1 | • | ||||
Katya D. Andresen2 | • | ||||
Mari J. Baker | • | « | • | ||
David C. Dobson | • | • | • | ||
Brian O. Hemphill | • | • | « | ||
Karen N. Madden | • | • | |||
Raymond W. McDaniel, Jr. | • | • | « | ||
William J. Pesce | • | • | • | ||
Inder M. Singh | • | « | • | ||
Jesse C. Wiley | « | ||||
Number of Meetings held in Fiscal Year 2025 | 6 | 7 | 6 | 1 | 8 |
28 | ![]() | 2025 Proxy Statement |
Corporate Governance |
Audit Committee | ||
Number of meetings in FY 2025: | 7 | |
Committee Members: | Inder Singh (Chair) Karen N. Madden Raymond W. McDaniel, Jr. | |
Primary Responsibilities: | ||
■Assisting the Board in fulfilling its fiduciary oversight responsibilities relating to the integrity of the Company’s financial statements filed with the SEC, accounting policies, adequacy of disclosures, the Company’s compliance with legal and regulatory requirements, the financial reporting process, the systems of internal accounting and financial controls established by management, the controls relating to corporate environmental, social and governance reporting, and the sufficiency of auditing relative thereto. ■Evaluating the qualification, independence and performance of the independent public accounting firm engaged to audit the Company’s financial statements, including reviewing and discussing with such firm their independence and whether providing any permitted non-audit services is compatible with their independence. ■Reviewing the performance and effectiveness of the internal audit function, including its objectives, responsibilities, and compliance with International Standards for the Professional Practice of Internal Auditing, and qualifications of the internal audit staff. ■Reviewing and approving the internal audit plan. ■Assisting the Board in fulfilling its oversight responsibilities regarding the Company’s policies and processes with respect to risk assessment and risk management, including overseeing the Company’s assessment and reporting of material risks and any significant non-financial risk exposures and reviewing reports from management on material risk topics. ■Coordinating with other committees of the Board and management to help ensure that the committees have received the information necessary to permit them to fulfill their duties and responsibilities with respect to oversight of risk. ■Overseeing the Company's legal, ethical and regulatory compliance program, including receiving updates from the General Counsel on legal matters that may have material impact on the Company's business, financial statements or compliance policies, and receiving reports on investigations of potentially significant alleged violations of laws, regulations or company policies. ■Establishing and maintaining oversight for the confidential and anonymous receipt, retention and treatment of complaints regarding the Company’s accounting, internal accounting controls, auditing matters and business conduct in accordance with the Business Conduct and Ethics Policy. ■Maintaining financial oversight of the Company’s employee retirement and other benefit plans and making recommendations to the Board with respect to such matters. ■Monitoring and providing oversight of technology and information security risks, including cybersecurity and data privacy, utilization of artificial intelligence, and controls implemented to monitor and mitigate these risks. ■Reviewing, ratifying and/or approving related person transactions. ■Reviewing and discussing quarterly earnings prior to its release, and also reviewing quarterly results prior to filings. Financial Expertise and Independence: The Board has determined that Raymond W. McDaniel, Jr. and Inder M. Singh satisfy the criteria adopted by the SEC to serve as “audit committee financial experts” and that all of the members of the Audit Committee are independent directors and financially literate pursuant to the applicable requirements under the SEC and NYSE rules. No Audit Committee member concurrently serves on the audit committee of more than two other public companies. Audit Committee Report: The Audit Committee Report is set forth beginning on page 45 of this Proxy Statement. | ||
2025 Proxy Statement | ![]() | 29 |
Corporate Governance |
Executive Compensation and Development Committee | ||
Number of meetings in FY 2025: | 6 | |
Committee Members: | Mari J. Baker (Chair) David C. Dobson William J. Pesce | |
Primary Responsibilities: | ||
■Overseeing all aspects of the executive compensation program and ensuring the program best achieves the Company’s objectives, considering the business strategy, talent needs, and market data trends, including overseeing the assessment of the risks related to the Company's compensation policies and programs. ■Annually evaluating the performance of the CEO, including relative to the achievement of approved goals and objectives, and reviewing and recommending for Board approval the CEO’s annual compensation based on the (i) CEO objectives approved by the Board, (ii) performance evaluations conducted by the Compensation Committee, and (iii) market and/or peer group data, including base salary, incentive compensation, equity compensation, and any perquisites. ■Reviewing and approving management’s recommendations, and providing guidance on matters relating to senior officer appointments, compensation levels, incentive plan goals, and award payouts, including any other key agreements. ■Leading the review of succession planning, development and talent assessment for executive officers (including the CEO) and other critical senior management roles, as needed; and discussing CEO succession planning and talent reviews with the full Board at least annually. ■Developing and maintaining of the emergency succession plan for the CEO. ■Reviewing and, when appropriate, approving the principles and policies for compensation and benefit programs company-wide, and reviewing and approving management's recommendations for adoption, implementation and/or amendment of qualified and non-qualified deferred compensation and pension plans. ■Overseeing the Company’s strategies, policies and practices related to human capital management, including culture, diversity, equity and inclusion, safety, pay equity, and talent management and development, including the ability to attract, develop, and retain talent needed to execute Company strategy. ■Overseeing and monitoring other compensation related policies and practices of the Company, including the Company's stock ownership guidelines for the CEO and Senior Officers, and the Company's recoupment clawback policies and procedures. ■Performing all the duties required of the Committee in connection with the Company's Annual and long- term Incentive Plans and Key Employee Stock Plans, as set forth in such plans. ■Assessing the independence of the compensation consultants, legal and other advisors to the Committee, and hiring and consulting with the independent Compensation Consultant. Independence: The Board of Directors has determined that all Compensation Committee members are independent directors pursuant to the applicable requirements under the SEC and NYSE rules. Limited Delegation of Authority to Management: The Compensation Committee has delegated limited authority to the CEO and the Chief People Officer to make certain “off-cycle” equity grants outside of the annual equity grant process to existing employees who are neither Company executive officers nor directors. The delegation is subject to maximum shares that can be granted per fiscal year, as well as a maximum to any one person per fiscal year. Shares awarded pursuant to this delegation will be valued based on the closing price of the Company’s stock on the NYSE as of the last day of the quarter and will be issued after quarter-end. Any grants made “off-cycle” are reported to the Compensation Committee at the next regularly scheduled quarterly meeting following such awards. Compensation Committee Report: The Compensation Committee Report is set forth beginning on page 77 of this Proxy Statement. | ||
30 | ![]() | 2025 Proxy Statement |
Corporate Governance |
Executive Committee | ||
Number of meetings in FY 2025: | 1 | |
Committee Members: | Raymond W. McDaniel, Jr. (Chair) Mari J. Baker Brian O. Hemphill Inder M. Singh Jesse C. Wiley | |
Primary Responsibilities: | ||
■Exercising the powers of the Board as appropriate between meetings of the Board, in any case where immediate action is required and the matter is such that a special interim meeting of the full Board is not deemed necessary or possible, including authority to act on urgent or time-sensitive matters, authority to act on behalf of the Board in a crisis when calling an emergency Board meeting will not result in a quorum, authority to act on specified matters delegated by the Board, and authority to provide final approval on matters previously reviewed by the full Board. ■Operating within specific limitations in accordance with applicable law, including having no authority over matters requiring shareholder approval, filling Board or committee vacancies, fixing director compensation, amending or repealing the Company's By-Laws, or amending/repealing non-amendable Board resolutions. ■Comprised of the chairs of other standing committees and the Board Chair, with the committee itself chaired by a seasoned director, ensuring experienced leadership and effective coordination across all Board committees. Independence: The Board of Directors has determined that all Executive Committee members, except for Mr. Wiley, are independent directors pursuant to the applicable requirements under the NYSE rules. | ||
2025 Proxy Statement | ![]() | 31 |
Corporate Governance |
Governance Committee | ||
Number of meetings in FY 2025: | 8 | |
Committee Members: | Brian O. Hemphill (Chair) David C. Dobson William J. Pesce | |
Primary Responsibilities: | ||
■Making recommendations to the Board regarding the size and composition of the Board and assisting the Board in determining the appropriate general qualifications and criteria for directorships and in the identification of qualified individuals to serve as directors and recommending Board candidates for nomination for election at the annual meeting of shareholders or to fill Board vacancies between annual meetings. ■Annually reviewing the independence guidelines set forth in the Corporate Governance Principles to determine, and recommend to the Board, whether the independent directors meet these standards. ■Reviewing and providing guidance on the annual objectives of the Chair of the Board and discussing such annual objectives with the Board. ■Evaluating the performance of the Chair of the Board relative to the approved objectives and discussing such performance evaluation with the Board. ■Developing and reviewing progress annually on the emergency and non-emergency succession planning for the Chair of the Board. ■Reviewing the composition and structure of standing committees and proposing committee assignments, including committee memberships and chairs to the Board. ■Coordinating and overseeing the annual Board self-evaluation process and presenting the results to the Board with recommendations, as appropriate. ■Monitoring and coordinating with management an orientation program for new directors to promote a basic understanding of Board policies and the Company's business and identifying continuing education programs for all Directors. ■Evaluating non-employee director compensation, including the compensation of the Board and committee chairs, and recommending such compensation to the Board. ■Periodically reviewing the Director travel and expense reimbursement guidelines. ■Reviewing annually the Corporate Governance Principles and recommending amendments to the Board, when necessary. ■Overseeing the Company’s environmental, social and governance strategy (ESG) and reporting, including belonging and inclusion and impacts of climate. Coordinating with the other committees of the Board, as appropriate, and management, to help ensure that the committees have received the information necessary to permit them to fulfill their duties and responsibilities with respect to oversight of the areas that fall within each committee’s area of responsibility. ■Reviewing, assessing, and pre-approving situations whereby Directors are seeking to join the board of another organization to confirm that there are no potential conflicts of interest or other concerns, and reviewing continued service of directors after material changes to their principal occupation. Independence: The Board of Directors has determined that all Governance Committee members are independent directors pursuant to the applicable requirements under the NYSE rules. | ||
32 | ![]() | 2025 Proxy Statement |
Corporate Governance |
2025 Proxy Statement | ![]() | 33 |
Corporate Governance |
34 | ![]() | 2025 Proxy Statement |
Corporate Governance |
2025 Proxy Statement | ![]() | 35 |
Corporate Governance |
36 | ![]() | 2025 Proxy Statement |
Corporate Governance |
2025 Proxy Statement | ![]() | 37 |
Corporate Governance |

Additional Annual Cash Retainers | ||
Board Chair | $150,000 | |
Committee Chairs | ||
Audit | $30,000 | |
Compensation | $20,000 | |
Governance | $17,500 | |
Ad hoc committees | $15,000 | |
Non-Chair Committee Members | ||
Audit | $15,000 | |
Compensation | $10,000 | |
Governance | $8,750 | |
Ad hoc committees | $7,500 |
38 | ![]() | 2025 Proxy Statement |
Corporate Governance |
2025 Proxy Statement | ![]() | 39 |
Corporate Governance |
Fiscal Year 2025 Director Compensation | |||||
Name | Cash Fee1 | Chair Fee1 | Stock Awards2 | All Other Compensation3,4 | Total |
Katya D. Andresen5 | — | — | — | — | — |
Mari J. Baker3,4 | $101,875 | $17,500 | $130,000 | $51,717 | $301,092 |
David C. Dobson3,6 | $101,875 | — | $130,000 | $36,305 | $268,180 |
Brian O. Hemphill3 | $96,250 | $8,750 | $130,000 | $13,558 | $248,558 |
Karen N. Madden4,7 | $8,888 | — | $74,750 | $2,661 | $86,299 |
Raymond W. McDaniel, Jr.3,8 | $107,500 | $23,750 | $130,000 | $88,286 | $349,536 |
William J. Pesce3,4 | $101,875 | $7,500 | $130,000 | $14,051 | $253,426 |
Inder M. Singh3,4 | $92,500 | $15,000 | $130,000 | $25,169 | $262,669 |
Jesse C. Wiley4,9 | $221,875 | $150,000 | $250 | $372,125 |
40 | ![]() | 2025 Proxy Statement |
Corporate Governance |
Name | Number of Shares Underlying Outstanding Deferred Stock Equivalent as of April 30, 2025 | Number of Shares Underlying Outstanding Stock Option |
Katya D. Andresen1 | — | — |
Mari J. Baker | 37,528 | — |
David C. Dobson | 27,201 | — |
Brian O. Hemphill | 10,505 | — |
Karen N. Madden | 1,890 | — |
Raymond W. McDaniel, Jr. | 57,324 | — |
Inder M. Singh | 11,670 | — |
William J. Pesce2 | — | — |
Jesse C. Wiley3 | — | — |
2025 Proxy Statement | ![]() | 41 |
Corporate Governance |
42 | ![]() | 2025 Proxy Statement |
2025 Proxy Statement | ![]() | 43 |
ESG and Corporate Impact |
44 | ![]() | 2025 Proxy Statement |
ESG and Corporate Impact |
2025 Proxy Statement | ![]() | 45 |
46 | ![]() | 2025 Proxy Statement |
Audit Committee Matters |
2025 Proxy Statement | ![]() | 47 |
The Board recommends a vote "FOR" the ratification of PwC as the Company's independent public accounting firm for the fiscal year ended April 30, 2026. |
48 | ![]() | 2025 Proxy Statement |
Proposal 2. Ratification of Appointment of Independent Registered Public Accounting Firm |
2025 | 2024 | |||
Audit Fees1 | $2,647,760 | $2,300,000 | ||
Audit-Related Fees2 | $0 | $135,000 | ||
Tax Fees3 | $494,571 | $205,000 | ||
All Other Fees4 | $2,000 | $78,000 |
2025 Proxy Statement | ![]() | 49 |
The Board recommends a vote "FOR" the approval, on an advisory basis, the compensation of the Named Executive Officers. |
50 | ![]() | 2025 Proxy Statement |
2025 Proxy Statement | ![]() | 51 |
Executive Compensation |
Name | Title |
Matthew S. Kissner | President and Chief Executive Officer ("CEO") 1 |
Christopher F. Caridi | Chief Accounting Officer and Former Interim Chief Financial Officer ("Interim CFO") 2 |
Christina Van Tassell | Former Executive Vice President and Chief Financial Officer ("Former CFO") 3 |
James J. Flynn II | Executive Vice President and General Manager, Research and Learning ("GM, R&L") |
Aref Matin | Former Executive Vice President and Chief Technology Officer ("Former CTO") 4 |
Danielle McMahan | Executive Vice President and Chief People Officer ("CPO") |
Deirdre P. Silver | Executive Vice President and General Counsel ("GC") |
52 | ![]() | 2025 Proxy Statement |
Executive Compensation |
Pay Mix | Pay for Performance | |
■Our pay mix emphasizes performance: for fiscal year 2025, 76% of our NEOs’ target total direct compensation was performance-based. ■Base salaries provide executive officers with market competitive fixed pay reflective of their role, experience and contributions, and allows us to attract and retain transformative talent. ■Annual incentive opportunities motivate and reward executive officers for driving short-term Company and business performance, and individual objectives that help drive long-term performance. ■Long-term incentives motivate and reward executive officers for driving sustainable financial results aligned with the business strategy and priorities, and the interest of our shareholders through the performance of our common stock. Our long-term incentive program is majority performance-based; for fiscal year 2025, under our Executive Long-Term Incentive Plan (“ELTIP”), we granted a mix of 60% performance share units ("PSUs") and 40% time-based restricted stock units ("RSUs"). | ■Annual incentives are funded at the Company level (excluding assets held for sale or sold during the fiscal year) and awarded based on personal performance; for fiscal year 2025, annual incentive awards for the NEOs ranged from 97% to 102% of target, reflecting Company funding at 102% of target, (based on adjusted revenue performance at 99% of target, adjusted operating income performance of 103% of target, and personal performance of 99% on average for the NEOs). ■PSUs that were eligible to vest this year (based on achievement against annual revenue and profit goals set at the beginning of each year in the fiscal year 2023 through 2025 cycle) paid out in aggregate at 87% of target (or ~83% of target value using fair market values on dates of grant and end of cycle due to a decline in stock price), reflecting mixed performance during the period. |


2025 Proxy Statement | ![]() | 53 |
Executive Compensation |
What We Do | |
a | Performance-based compensation: A significant portion of our NEOs’ target total direct compensation is performance-based |
a | Range of payout: Financial performance levels are set that correspond to a range of incentive payments from threshold to maximum |
a | Formulaic framework: Incentive payments are based on the Company’s financial results relative to pre-established targets |
a | Robust clawback policy: All executive officer performance-based cash and stock awards are covered for material financial restatements, in compliance with SEC and listing exchange rules, and in addition are subject to a potentially greater clawback amount or complete forfeiture in the event fraud or misconduct caused the need for a restatement |
a | Double trigger vesting: Only applies if an executive is involuntarily terminated without cause or resigns for good reason within two years of a change in control, or if the awards are not assumed or replaced by the acquirer |
a | Rigorous stock ownership requirements: Executive officers have stock ownership requirements, including retention of 50% of equity-based awards until the requirement is met |
a | Limited perquisites: Perquisites are offered only where doing so serves a reasonable business purpose |
a | Risk mitigation: As noted earlier in the Oversight of Compensation Risk section on page 35, we closely monitor risks associated with our compensation programs and individual compensation decisions to confirm that they do not encourage excessive risk-taking |
What We Don't Do | |
x | No hedging and pledging: Under our Insider Trading Policy, executive officers are prohibited from hedging and pledging Company stock |
x | No repricing or buyouts: We do not reprice stock option awards and our plans expressly forbid exchanging underwater options for cash |
x | No tax gross-ups: We do not provide excise tax gross-ups on change in control-related payments; or tax gross-ups on perquisites, with the exception of relocation or tax equalization |
x | No supplemental benefit programs: We do not provide significant additional health and retirement benefits to executive officers that differ from those provided to all other colleagues |
54 | ![]() | 2025 Proxy Statement |
Executive Compensation |
Party | Primary Roles |
Executive Compensation & Development Committee | ■Oversee all aspects of the executive compensation program ■Approve officer compensation levels, incentive plan goals, and award payouts ■Review CEO goals and objectives, evaluate CEO performance, and recommend CEO compensation to the full Board of Directors for approval ■Ensure the executive compensation program best achieves the Company’s objectives, considering the business strategy, talent needs, and market trends ■Hire and consult with the Compensation Consultant and determine the nature and scope of services provided |
CEO and Company Management | ■Make recommendations regarding the potential structure of the executive compensation program, including input on key business strategies and objectives ■Make recommendations regarding the compensation levels of the executive officers and other executive leaders (excluding the CEO) ■Liaise with the Compensation Consultant as necessary in support of the Executive Compensation Program ■Provide any other information requested by the Compensation Committee |
Compensation Consultant | ■Advise the Compensation Committee on competitive market practices and trends ■Provide proxy pay data for our compensation peer group ■Present information and comparative market data regarding specific executive compensation matters, as requested by the Compensation Committee ■Review and provide advice on management proposals ■Provide compliance and regulatory updates ■Provide recommendations regarding CEO pay ■Review the Compensation Discussion and Analysis annually |
2025 Proxy Statement | ![]() | 55 |
Executive Compensation |
Cable One, Inc. | Gray Media, Inc. | Scholastic Corporation |
Entravision Communications Corporation | IAC Inc. | Stagwell Inc. |
The E.W. Scripps Co. | Lee Enterprises, Incorporated | TEGNA Inc. |
Gannett Co., Inc. | The New York Times Company | Thryv Holdings, Inc. |
Graham Holdings Company | Pearson Plc | Wolters Kluwer NV |

56 | ![]() | 2025 Proxy Statement |
Executive Compensation |
Named Executive Officer | Base Salary as of 2024 Fiscal Year End | Base Salary as of 2025 Fiscal Year End | Percentage Increase |
Matthew S. Kissner (CEO) | $900.0 | $900.0 | —% |
Christopher F. Caridi (Interim CFO) | $397.7 | $450.0 | 13% |
Christina Van Tassell (Former CFO) | $650.0 | $650.0 | —% |
James J. Flynn II (GM, R&L) | $500.0 | $500.0 | —% |
Aref Matin (Former CTO) | $460.0 | $460.0 | —% |
Danielle McMahan (CPO) | $455.0 | $485.0 | 7% |
Deirdre P. Silver (GC) | $435.0 | $465.0 | 7% |
2025 Proxy Statement | ![]() | 57 |
Executive Compensation |

Measure | Weighting | Target | Threshold Level | Outstanding Level | Adjusted Actual | % of Target Achieved | % Funded |
Adjusted Revenue1 | 50% | $1,681 | 95% | 105% | $1,660 | 99% | 43.8% |
Adjusted Operating Income2 | 50% | $244 | 90% | 110% | $252 | 103% | 58.6% |
Total | 102% |
58 | ![]() | 2025 Proxy Statement |
Executive Compensation |
Named Executive Officer | Target Incentive Percentage | Target Incentive Award ($000s) | Actual Incentive Award ($000s) | Actual Award as Percentage of Target |
Matthew S. Kissner (CEO) | 150% | $1,350.0 | $1,377.0 | 102.0% |
Christopher F. Caridi (Interim CFO) | 85% | $382.5 | $390.2 | 102.0% |
James J. Flynn II (GM, R&L) | 100% | $500.0 | $485.0 | 97.0% |
Danielle McMahan (CPO) | 85% | $412.3 | $420.5 | 102.0% |
Deirdre P. Silver (GC) | 75% | $348.8 | $355.7 | 102.0% |
2025 Proxy Statement | ![]() | 59 |
Executive Compensation |

Target Number of FY23-25 PSUs | ||||
Named Executive Officer | Full PSU ($000s) | Year One (Granted in FY23) | Year Two (Granted in FY24) | Year Three (Granted in FY25) |
Christopher F. Caridi (Interim CFO) | $109 | 789 | 790 | 790 |
Christina Van Tassell (Former CFO)1 | $734 | 5,317 | 5,317 | 5,317 |
James J. Flynn II (GM, R&L) | $430 | 3,113 | 3,114 | 3,114 |
Aref Matin (Former CTO)1 | $649 | 4,703 | 4,704 | 4,704 |
Danielle McMahan (CPO) | $340 | 2,462 | 2,462 | 2,463 |
Deirdre P. Silver (GC) | $320 | 2,319 | 2,319 | 2,319 |
60 | ![]() | 2025 Proxy Statement |
Executive Compensation |
Measure | Weighting | Target ($000s) | Threshold Level | Outstanding Level | Adjusted Actual ($000s) | % of Target Achieved | % of Award Earned |
Adjusted Revenue1 | 50% | $1,681 | 95% | 105% | $1,660 | 99% | 43.8% |
Adjusted EBITDA2 | 50% | $395 | 85% | 115% | $399 | 101% | 53.5% |
Total | 97% |
2025 Proxy Statement | ![]() | 61 |
Executive Compensation |
Named Executive Officer | Fiscal Year | Target PSUs | Earned PSUs | Earned PSUs as % of Target |
Christopher F. Caridi (Interim CFO) | FY25 | 790 | 766 | 97.0% |
FY24 | 790 | 956 | 121.0% | |
FY23 | 789 | 339 | 43.0% | |
Christina Van Tassell (Former CFO)1 | FY25 | 4,283 | 4,155 | 97.0% |
FY24 | 4,283 | 5,182 | 121.0% | |
FY23 | 4,283 | 1,842 | 43.0% | |
James J. Flynn (GM, R&L) | FY25 | 3,114 | 3,021 | 97.0% |
FY24 | 3,114 | 3,768 | 121.0% | |
FY23 | 3,113 | 1,339 | 43.0% | |
Aref Matin (Former CTO)1 | FY25 | 4,051 | 3,929 | 97.0% |
FY24 | 4,051 | 4,902 | 121.0% | |
FY23 | 4,050 | 1,741 | 43.0% | |
Danielle McMahan (CPO) | FY25 | 2,463 | 2,389 | 97.0% |
FY24 | 2,462 | 2,979 | 121.0% | |
FY23 | 2,462 | 1,059 | 43.0% | |
Deirdre P. Silver (GC) | FY25 | 2,319 | 2,249 | 97.0% |
FY24 | 2,319 | 2,806 | 121.0% | |
FY23 | 2,319 | 997 | 43.0% |
62 | ![]() | 2025 Proxy Statement |
Executive Compensation |
![]() | Health and wellness plans The Company provides a wide variety of health and welfare benefits globally. Additionally, the company provides or makes available medical, dental, vision, life, accident and long-term disability insurance to all US- based colleagues, including the executive officers. These competitive benefits are provided primarily for the well-being of Wiley colleagues, and at the same time enhance Wiley’s attractiveness as an employer of choice. | ![]() | Post-employment compensation Depending on the circumstances of their termination, the executive officers are eligible to receive severance benefits in the form of base salary as a lump-sum payment, annual incentive, healthcare benefits and accelerated vesting of equity as determined by the provisions in their employment agreements or the Executive Severance Plan. Under a dismissal without cause or constructive discharge following a change in control, the Company provides these severance benefits because it serves the best interest of the Company and its shareholders to have executives focus on the business merits of mergers and acquisitions without undue concern for their personal financial outcome. In the case of a without cause termination or constructive discharge absent a change in control, the Company believes it is appropriate to provide severance for a limited period to bridge executives to new employment, particularly in view of our non-compete and non-solicitation covenants. |
![]() | Perquisites and other personal benefits The Company provides limited perquisites and other personal benefits to the executive officers, including financial planning and tax preparation, an allowance for business and health club memberships, and reimbursement of public transportation commuting expenses and/or parking at the Company's headquarters. These taxable benefits are provided primarily for the financial security and productivity of executives, which allows greater focus on Company business activities. | ||
![]() | Retirement benefits All NEOs are eligible to participate in the Company’s qualified Employees’ Savings Plan (“401(k) Plan”). However, because US tax rules governing qualified retirement plans place significant limitations on the benefits that can be paid to executives, the Company has a non-qualified retirement plan to supplement qualified retirement benefits. The Nonqualified Deferred Compensation Plan (the “NQDC Plan”) was adopted by the Board of Directors to provide the opportunity to defer compensation for those executives who are not able to take full advantage of the Company’s qualified Savings Plan because of tax rules limiting contributions. The NQDC Plan provides for Company contributions mirroring those made under the Savings Plan when an eligible officer participates in the plan. | ||
2025 Proxy Statement | ![]() | 63 |
Executive Compensation |
![]() | Clawback Provisions To ensure that our compensation program does not encourage excessive risk taking the Company maintains clawback and forfeiture provisions in both the annual and long-term incentive plans (applicable to cash incentives and performance-based equity awards) covering approximately the top 400 employees in the Company. The clawback provisions allow the Company to recoup excess incentive payments to covered participants in the event that the Company restates its financial results, or to recoup entire award amounts from an individual in the event that fraud, gross negligence or intentional misconduct contributed to the need for the restatement. In addition, the Company maintains a separate clawback policy applicable to executive officers that also covers incentive compensation in the event of a financial restatement, and complies with SEC and listing exchange rules. | ![]() | Stock Ownership Guidelines The Compensation Committee believes that the ultimate goal of the long-term incentive program is to align the interests of Company shareholders and management. To reinforce this principle, the Compensation Committee established stock ownership guidelines for all executive officers participating in the long- term incentive program. The ownership multiple for the CEO is six times base salary. The ownership multiple for the other NEOs is two and one-half times base salary. Mr. Caridi who is a Senior Vice President has an ownership multiple of one time his base salary. Shares counted toward the ownership guidelines consist of: ▪Shares owned outright ▪Subject to the award being earned/ vested, half of the performance share units earned when performance goals are achieved. (assumes half will be surrendered to pay taxes.) ▪Half of time-based RSUs granted. (assumes half will be surrendered to pay taxes.) Unearned PSUs and stock options do not count toward the ownership guidelines. There is a stock retention requirement for our executive officers that requires retention of 50% of the net shares acquired upon the exercise of stock options or the vesting of PSUs and RSUs until the executive satisfies the stock ownership multiple. All of the NEOs are in compliance with the retention requirements under the guidelines and have met or made good progress toward their targeted stockholding multiple. |
![]() | Hedging and Pledging Prohibition As part of our Insider Trading Policy, which applies to employees and directors, the Company prohibits: ▪any type of hedging activity, including the use of financial instruments such as prepaid variable forwards, equity swaps, collars and/or exchange funds ▪entering into short sales or purchasing, selling or exercising puts, calls or other such options pertaining to stock of the Company ▪holding securities of the Company in a margin account or otherwise pledging securities of the Company as collateral for a loan |
64 | ![]() | 2025 Proxy Statement |
Executive Compensation |
Name and Principal Position | Fiscal Year | Salary1 ($) | Bonus ($) | Stock Awards2 ($) | Option Awards3 ($) | Non-Equity Incentive Plan Compensation4 ($) | Change in Pension Value and Non- Qualified Deferred Compensation Earnings5 ($) | All Other Compensation6 ($) | Total ($) |
Matthew S. Kissner (CEO) | 2025 | $900.0 | — | $3,171.3 | $1,377.0 | $15.4 | $84.5 | $5,548.3 | |
2024 | $487.5 | — | $1,694.2 | $127.6 | $885.7 | $(92.4) | $255.1 | $3,357.7 | |
Christopher F. Caridi (Interim CFO) | 2025 | $408.8 | — | $277.2 | $390.2 | $31.3 | $26.3 | $1,133.8 | |
Christina Van Tassell (Former CFO) | 2025 | $272.6 | — | $1,736.0 | $18.1 | $713.4 | $2,740.2 | ||
2024 | $650.0 | — | $1,583.3 | $127.6 | $521.6 | $18.3 | $67.5 | $2,968.4 | |
2023 | $650.0 | — | $953.7 | — | $325.0 | $2.9 | $84.5 | $2,016.0 | |
James J. Flynn II (GM, R&L) | 2025 | $500.0 | — | $1,576.0 | $485.0 | $41.2 | $168.3 | $2,770.5 | |
2024 | $473.3 | — | $1,245.0 | $127.6 | $588.5 | $28.7 | $49.5 | $2,512.6 | |
2023 | $441.7 | — | $487.0 | — | $230.0 | $17.3 | $61.7 | $1,237.7 | |
Aref Matin (Former CTO) | 2025 | $270.9 | — | $1,535.7 | $174.4 | $511.1 | $2,492.0 | ||
2024 | $460.0 | — | $1,385.2 | $127.6 | $492.2 | $194.7 | $37.8 | $2,697.6 | |
2023 | $460.0 | — | $822.8 | — | $230.0 | $92.8 | $79.6 | $1,685.1 | |
Danielle McMahan (CPO) | 2025 | $480.0 | — | $1,003.1 | $420.5 | $6.9 | $38.8 | $1,949.4 | |
2024 | $455.0 | — | $845.3 | $127.6 | $538.0 | $6.4 | $53.2 | $2,025.4 | |
Deirdre P. Silver (GC) | 2025 | $460.0 | — | $906.5 | $355.7 | $34.3 | $62.0 | $1,818.5 |
2025 Proxy Statement | ![]() | 65 |
Executive Compensation |
■Employer contributions to the Company 401(k) Plan and NQDC Plan for Mr. Kissner $64.9K, Mr. Caridi $23.8K, Ms. Van Tassell $33.8K, Mr. Flynn $45.0K, Mr. Matin $32.3K, Ms. McMahan $14.9K and Ms. Silver $34.1K. |
■Perquisites (financial planning, health club membership fees, commuter benefits) for Mr. Kissner $13.6K, Ms. Van Tassell $29.1K, Mr. Flynn $21.2K, Mr. Matin $18.8K, Ms. McMahan $22.5K and Ms. Silver $21.2. |
■Charitable donations pursuant to the Company’s Matching Gift Program paid to charities on behalf of Mr. Kissner $6K, Mr. Caridi $2.5K, Ms. Van Tassell $0.5K, Ms. McMahan $1.5K, and Ms. Silver $6.65K. |
■Severance for Ms. Van Tassell in the amount of $650K, and Mr. Matin in the amount of $460K. |
■Relocation related expenses in the amount of $102.1K for Mr. Flynn who moved to the UK for business purposes for a twelve-month period. |
66 | ![]() | 2025 Proxy Statement |
Executive Compensation |
Named Executive Officer | Estimated Possible Payouts Under Non-Equity Incentive Plan Awards1 | Estimated Future Payouts Under Equity Incentive Plan Awards2 | All Other Stock Awards: Number of Shares of Stock Units3 | All Other Option Awards: Number of Securities Underlying Options | Grant Date Fair Value of Stock and Option Awards ($000s) 4 | |||||
Grant Date | Threshold ($000s) | Target ($000s) | Maximum ($000s) | Threshold (#) | Target (#) | Maximum (#) | ||||
Matthew S. Kissner (CEO) | $675 | $1,350 | $4,050 | |||||||
7/15/2024 | 20,395 | 40,789 | 81,578 | $1,903 | ||||||
7/15/2024 | 27,192 | $1,269 | ||||||||
Chris F. Caridi (Interim CFO) | $192 | $383 | $1,149 | — | — | — | ||||
7/15/2024 | 1,640 | 3,279 | 6,558 | $153 | ||||||
7/15/2024 | 395 | 790 | 1,580 | $37 | ||||||
6/26/2024 | 2,186 | $87 | ||||||||
Christina Van Tassell (Former CFO) | $325 | $650 | $1,950 | |||||||
7/15/2024 | 10,149 | 20,297 | 40,594 | $947 | ||||||
7/15/2024 | 2,659 | 5,317 | 10,634 | $248 | ||||||
6/26/2024 | 13,531 | $541 | ||||||||
James J. Flynn, (GM, R&L) | $250 | $500 | $1,500 | |||||||
7/15/2024 | 9,758 | 19,516 | 39,032 | $910 | ||||||
7/15/2024 | 1,557 | 3,114 | 6,228 | $145 | ||||||
6/26/2024 | 13,011 | $520 | ||||||||
Aref Matin (Former CTO) | $230 | $460 | $1,380 | |||||||
7/15/2024 | 8,978 | 17,955 | 35,910 | $838 | ||||||
7/15/2024 | 2,352 | 4,704 | 9,408 | $219 | ||||||
6/26/2024 | 11,970 | $479 | ||||||||
Danielle McMahan (CPO) | $206 | $412 | $1,236 | |||||||
7/15/2024 | 6,058 | 12,116 | 24,232 | $565 | ||||||
7/15/2024 | 1,232 | 2,463 | 4,926 | $115 | ||||||
6/26/2024 | 8,077 | $323 | ||||||||
Deirdre P. Silver (GC) | $175 | $349 | $1,047 | |||||||
7/15/2024 | 5,445 | 10,890 | 21,780 | $508 | ||||||
7/15/2024 | 1,160 | 2,319 | 4,638 | $108 | ||||||
6/26/2024 | 7,260 | $290 |
2025 Proxy Statement | ![]() | 67 |
Executive Compensation |
68 | ![]() | 2025 Proxy Statement |
Executive Compensation |
Named Executive Officer | Number of Securities Underlying Unexercised Vested Options (#) | Number of Securities Underlying Unexercised Unvested Options (#) | Option Exercise Price ($)1 | Option Expiration Date2 | Number of Shares or Units of Stock That Have Not Vested (#) | Market Value of Shares or Units of Stock That Have Not Vested ($000s)3 | Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights that have not Vested (#) | Equity Incentive Plan Awards: Market or Payout of Unearned Shares, Units or Other Rights that have not Vested ($000s)3 |
Matthew S. Kissner (CEO) | 6,000 | 14,000 | $35.00 | 11/2/2033 | 10,014 C | $437.0 | 35,538 | $1,550.9 E |
20,394 D | $890.0 | 40,789 | $1,780.0 F | |||||
Christopher F. Caridi (Interim CFO) | 2,061 A | $89.9 | 3,926 | $171.3 E | ||||
395 B | $17.2 | 3,279 | $143.1 F | |||||
1,152 C | $50.3 | |||||||
2,715 G | $118.5 | |||||||
1,640 D | $71.6 | |||||||
Christina Van Tassell (Former CFO) | 11,179 A | $487.9 | 12,120 | $528.9 E | ||||
James J. Flynn, (GM, R&L) | 743 | — | $55.99 | 6/23/2025 | 8.128 A | $354.7 | 22,705 | $990.8 E |
20,000 | — | $63.07 | 9/27/2031 | 1,557 B | $67.9 | 19,516 | $851.7 F | |
6,000 | 14,000 | $35.00 | 11/2/2033 | 6,659 C | $290.6 | |||
9,759 D | $425.9 | |||||||
Aref Matin (Former CTO) | 10,572 A | $461.4 | 11,983 | $522.9 E | ||||
Danielle McMahan (CPO) | 20,000 | — | $63.07 | 6/23/2031 | 6,427 A | $280.5 | 14,373 | $627.2 E |
6,000 | 14,000 | $35.00 | 11/2/2033 | 1,231 B | $53.7 | 12,116 | $528.7 F | |
4,216 C | $184.0 | |||||||
6,058 D | $264.4 | |||||||
Deirdre P. Silver (GC) | 20,000 | — | $63.07 | 6/23/2031 | 6,052 A | $264.1 | 12,883 | $562.2 E |
6,000 | 14,000 | $35.00 | 11/2/2033 | 1,160 B | $50.6 | 10,890 | $475.2 F | |
3,778 C | $164.9 | |||||||
5,445 D | $237.6 |
2025 Proxy Statement | ![]() | 69 |
Executive Compensation |
Option Awards | Stock Awards | |||
Named Executive Officer | Number of Shares Acquired on Exercise (#) | Value Realized on Exercise ($000s) | Number of Shares Acquired on Vesting (#)1 | Value Realized on Vesting2 ($000s) |
Matthew S. Kissner (CEO) | — | — | 11,805 | $515.2 |
Christopher Caridi (Interim CFO) | — | — | 4,427 | $185.6 |
Christina Van Tassell (Former CFO) | 2,000 | $17.5 | 12,203 | $496.5 |
James J. Flynn II (GM, R&L) | — | — | 11,949 | $512.1 |
Aref Matin (Former CTO) | 2,000 | $10.6 | 9,638 | $392.2 |
Danielle McMahan (CPO) | — | — | 11,394 | $482.3 |
Deirdre P. Silver (GC) | — | — | 10,001 | $423.8 |
70 | ![]() | 2025 Proxy Statement |
Executive Compensation |
Named Executive Officer | Executive Contributions in Fiscal Year 2025 ($) | Registrant Contributions in Fiscal Year 2025 ($) | Aggregate Earnings in Fiscal Year 2025 ($) | Aggregate Withdrawals/ Distributions Fiscal Year 2025 ($) | Aggregate Balance at 2025 Fiscal Year End ($) |
Matthew S. Kissner (CEO) | $311.4 | $50.9 | $15.5 | $(108.4) | $510.1 |
Christopher F. Caridi (Interim CFO) | $85.5 | $8.8 | $31.3 | — | $432.3 |
Christina Van Tassell (Former CFO) | $47.7 | $27.5 | $18.1 | $(290.6) | — |
James J. Flynn II (GM, R&L) | $70.6 | $30.4 | $34.5 | — | $740.8 |
Aref Matin (Former CTO) | $45.6 | $23.2 | $174.4 | — | $3,785.2 |
Danielle McMahan (CPO) | $1.6 | — | $4.1 | — | $90.1 |
Deirdre P. Silver (GC) | $141.1 | $19.0 | $34.3 | — | $636.2 |
2025 Proxy Statement | ![]() | 71 |
Executive Compensation |
72 | ![]() | 2025 Proxy Statement |
Executive Compensation |
Matthew S. Kissner (CEO) | Voluntary Termination of Employment | Involuntary Termination of Employment without Cause, or Constructive Discharge (absent CoC) | Involuntary Termination of Employment without Cause, or Constructive Discharge (following CoC) | Termination of Employment Due to Death or Permanent Disability |
Severance – Base Salary | — | — | — | — |
Severance – Annual Incentive | — | — | — | — |
Target Annual Incentive | — | $1,350.0 | $1,350.0 | $1,350.0 |
ELTIP – Restricted Performance Share Units | — | $3,330.9 | $3,330.9 | $3,330.9 |
Performance Share Units Earned but Not Vested | — | — | — | — |
Restricted Share Units (Time-based) | — | $1,327.0 | $1,327.0 | $1,327.0 |
Stock Options | — | — | $121.0 | — |
Benefits | — | $39.5 | $45.3 | — |
Total (All data in $000s) | $0.0 | $6,047.4 | $6,174.2 | $6,007.9 |
Christina Van Tassell (Former CFO) | Actual Payments Made Upon Involuntary Termination without Cause |
Severance – Base Salary | $650.0 |
Earned Annual Incentive | — |
ELTIP – Restricted Performance Share Units 1 | $487.9 |
Performance Share Units Earned but Not Vested 2 | $528.9 |
Restricted Share Units (Time-based) | — |
Benefits | $15.4 |
Total (All data in $000s) | $1,682.2 |
2025 Proxy Statement | ![]() | 73 |
Executive Compensation |
Christopher F. Caridi (Interim CFO) | Voluntary Termination of Employment | Involuntary Termination of Employment without Cause, or Constructive Discharge (absent CoC) | Involuntary Termination of Employment without Cause, or Constructive Discharge (following CoC) | Termination of Employment Due to Death or Permanent Disability |
Severance – Base Salary | — | $450.0 | $450.0 | — |
Severance – Annual Incentive | — | — | $382.5 | — |
Target Annual Incentive | — | $382.5 | $382.5 | $382.5 |
ELTIP – Restricted Performance Share Units | — | $161.9 | $314.4 | $161.9 |
Performance Share Units Earned but Not Vested | — | $89.9 | $89.9 | $89.9 |
Restricted Share Units (Time-based) | — | — | $257.3 | $257.3 |
Stock Options | — | — | — | — |
Benefits | — | $25.5 | $25.5 | — |
Total (All data in $000s) | $0.0 | $1,109.8 | $1,902.1 | $891.6 |
James J. Flynn II (GM, R&L) | Voluntary Termination of Employment | Involuntary Termination of Employment without Cause, or Constructive Discharge (absent CoC) | Involuntary Termination of Employment without Cause, or Constructive Discharge (following CoC) | Termination of Employment Due to Death or Permanent Disability |
Severance – Base Salary | — | $583.3 | $750.0 | — |
Severance – Annual Incentive | — | — | $750.0 | — |
Target Annual Incentive | — | $500.0 | $500.0 | $500.0 |
ELTIP – Restricted Performance Share Units | — | $944.5 | $1,842.5 | $944.5 |
Performance Share Units Earned but Not Vested | — | $354.7 | $354.7 | $354.7 |
Restricted Share Units (Time-based) | — | — | $784.4 | $784.4 |
Stock Options | — | — | $121.0 | — |
Benefits | — | $30.8 | $31.7 | — |
Total (All data in $000s) | $0.0 | $2,413.3 | $5,134.3 | $2,583.6 |
74 | ![]() | 2025 Proxy Statement |
Executive Compensation |
Aref Matin (Former CTO) | Actual Payments Made Upon Involuntary Termination without Cause |
Severance – Base Salary | $460.0 |
Earned Annual Incentive | — |
ELTIP – Restricted Performance Share Units 1 | $522.9 |
Performance Share Units Earned but Not Vested 2 | $461.4 |
Restricted Share Units (Time-based) | — |
Benefits | $18.4 |
Total (All data in $000s) | $1,462.7 |
Danielle McMahan (CPO) | Voluntary Termination of Employment | Involuntary Termination of Employment without Cause, or Constructive Discharge (absent CoC) | Involuntary Termination of Employment without Cause, or Constructive Discharge (following CoC) | Termination of Employment Due to Death or Permanent Disability |
Severance – Base Salary | — | $485.0 | $727.5 | — |
Severance – Annual Incentive | — | — | $618.4 | — |
Target Annual Incentive | — | $412.3 | $412.3 | $412.3 |
ELTIP – Restricted Performance Share Units | — | $594.4 | $1,156.0 | $594.4 |
Performance Share Units Earned but Not Vested | — | $280.5 | $280.5 | $280.5 |
Restricted Share Units (Time-based) | — | — | $502.1 | $502.1 |
Stock Options | — | — | $121.0 | — |
Benefits | — | $52.3 | $64.4 | — |
Total (All data in $000s) | $0.0 | $1,824.5 | $3,882.2 | $1,789.3 |
2025 Proxy Statement | ![]() | 75 |
Executive Compensation |
Deirdre P. Silver (GC) | Voluntary Termination of Employment | Involuntary Termination of Employment without Cause, or Constructive Discharge (absent CoC) | Involuntary Termination of Employment without Cause, or Constructive Discharge (following CoC) | Termination of Employment Due to Death or Permanent Disability |
Severance – Base Salary | — | $697.5 | $697.5 | — |
Severance – Annual Incentive | — | — | $523.1 | — |
Target Annual Incentive | — | $348.8 | $348.8 | $348.8 |
ELTIP – Restricted Performance Share Units | — | $533.2 | $1,037.5 | $533.2 |
Performance Share Units Earned but Not Vested | — | $264.1 | $264.1 | $264.1 |
Restricted Share Units (Time-based) | — | — | $453.1 | $453.1 |
Stock Options | — | — | $121.0 | — |
Benefits | — | $45.3 | $45.3 | — |
Total (All data in $000s) | $0.0 | $1,888.9 | $3,490.4 | $1,599.2 |
76 | ![]() | 2025 Proxy Statement |
Executive Compensation |
2025 Proxy Statement | ![]() | 77 |
Executive Compensation |
78 | ![]() | 2025 Proxy Statement |
Executive Compensation |
2025 Proxy Statement | ![]() | 79 |
Executive Compensation |
Year (a) | Summary Compensation Table Total for PEO1,2,3($000) (b) | Compensation Actually Paid to PEO1,2,3 ($000) (c) | Average Summary Compensation Table Total for Non-PEO NEOs1 (d) | Average Compensation Actually Paid to Non-PEO NEOs1,4,5 (e) | Value of Initial Fixed $100 Investment based on:4 | Net Income (GAAP) ($ Millions)7 (h) | Adjusted Revenue ($ Millions)8 (i) | |||
TSR ($) (f) | Peer Group TSR ($) (g) | |||||||||
PEO2 | PEO3 | PEO2 | PEO3 | |||||||
2025 | $ | $ | $ | $ | $ | $ | $ | $ | ||
2024 | $ | $ | $ | $ | $ | $ | $ | $ | -$ | $ |
2023 | $ | $ | $ | $ | $ | $ | $ | $ | ||
2022 | $ | $ | $ | $ | $ | $ | $ | $ | ||
2021 | $ | $ | $ | $ | $ | $ | $ | $ |
2025 | 2024 | 2023 | 2022 | 2021 |
Christopher F. Caridi | Christina Van Tassell | Christina Van Tassell | John A. Kritzmacher | John A. Kritzmacher |
Christina Van Tassell | James J. Flynn II | Aref Matin | Christina Van Tassell | Todd R. Zipper |
James J. Flynn II | Aref Matin | Todd R. Zipper | Aref Matin | Matthew S. Kissner |
Aref Matin | Danielle McMahan | James J. Flynn II | Todd R. Zipper | Judy K. Verses |
Danielle McMahan | Matthew H. Leavy | |||
Deirdre P. Silver |
80 | ![]() | 2025 Proxy Statement |
Executive Compensation |
2025 | 2024 | 2023 | 2022 | 2021 | |||||||
PEO | Average Non- PEO NEOs | PEO Kissner | PEO Napack | Average Non- PEO NEOs | PEO | Average Non- PEO NEOs | PEO | Average Non- PEO NEOs | PEO | Average Non- PEO NEOs | |
Summary Compensation Table Total (All data in $000s) | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ |
Less Stock Award Value & Option Award Value Reported in SCT for the Covered Year | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ |
Plus Year End Fair Value of Equity Awards Granted During the Covered Year that Remain Outstanding and Unvested as of Last Day of the Covered Year | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ |
Plus Year over Year Change in Fair Value as of the Last Day of the Covered Year from Last Day of the Prior Year of Outstanding and Unvested Equity Awards Granted in Prior Years | $ | $ | $ | $( | $( | $( | $( | $( | $( | $ | $( |
Plus Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Covered Year | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ |
Plus Year over Year Change in Fair Value as of the Vesting Date of Equity Awards Granted in Prior Years that Vested During the Covered Year | $ | $ | $( | $( | $( | $( | $( | $( | $ | $ | $ |
Minus Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Covered Year | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ |
Compensation Actually Paid | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ |
2025 Proxy Statement | ![]() | 81 |
Executive Compensation |


82 | ![]() | 2025 Proxy Statement |
Executive Compensation |

2025 Proxy Statement | ![]() | 83 |
Named Executive Officers and Directors | Title of Class | Shares Beneficially Owned1,2 | Shares and Share Equivalents Under Deferred Plan1,3 | Percent of Class | Percent of Voting Power4 |
Craig M. Albright5 | A | — | — | — | — |
B | — | — | — | — | |
Katya D. Andresen | A | — | 784 | — | — |
B | — | — | — | — | |
Mari J. Baker | A | — | 37,866 | — | — |
B | — | — | — | — | |
Christopher F. Caridi5 | A | 7,928 | — | * | * |
B | — | — | — | — | |
David C. Dobson | A | — | 27,201 | * | — |
B | — | — | — | — | |
James J. Flynn II5,9 | A | 41,427 | — | * | * |
B | — | — | — | — | |
Brian O. Hemphill | A | — | 10,599 | — | — |
B | — | — | — | — | |
Matthew S. Kissner5,6,9 | A | 43,093 | — | * | * |
B | — | — | — | — | |
Karen N. Madden | A | — | 1,874 | — | — |
B | — | — | — | — | |
Aref Matin7 | A | 40,273 | — | * | — |
B | — | — | — | — | |
Raymond W. McDaniel, Jr. | A | 500 | 57,841 | * | * |
B | — | — | — | — | |
Danielle McMahan5,9 | A | 41,625 | — | * | * |
B | — | — | — | — | |
William J. Pesce8 | A | 88,108 | — | * | * |
B | — | — | — | — | |
Deirdre P. Silver5,9 | A | 50,920 | — | * | * |
B | — | — | — | — | |
Inder M. Singh | A | — | 11,775 | — | — |
B | — | — | — | — | |
Jesse C. Wiley10 | A | 462,338 | — | 1.04% | * |
B | 8,150,101 | — | 92.95% | 61.63% | |
Christina Van Tassell7 | A | 16,926 | — | * | |
B | — | — | — | — | |
All current directors and executive officers as a group (19 persons)11 | A | 746,856 | 147,941 | * | 7.00% |
B | 8,150,201 | — | * | 6.16% |
84 | ![]() | 2025 Proxy Statement |
Ownership of Common Stock |
2025 Proxy Statement | ![]() | 85 |
Ownership of Common Stock |
Name | Title Of Class | Amount And Nature Of Beneficial Ownership | Percent Of Class | Percentage Of Voting Power1 |
E.P. Hamilton Trusts, LLC2,10 | A | 462,338 | 1.04% | 0.35% |
B | 8,125,536 | 92.67% | 61.45% | |
Celia Wiley2,3,4,10 | A | 462,338 | 1.04% | 0.35% |
B | 8,150,599 | 92.96% | 61.64% | |
Deborah E. Wiley2,3,5,10,11,12,13 | A | 2,754,185 | 6.08% | 2.04% |
B | 8,193,815 | 93.45% | 61.96% | |
Elizabeth Wiley2,3,6,10 | A | 462,338 | 1.04% | 0.35% |
B | 8,128,336 | 92.71% | 61.47% | |
Jesse C. Wiley2,3,7,10 | A | 462,338 | 1.04% | 0.35% |
B | 8,150,101 | 92.95% | 61.63% | |
Peter B. Wiley2,3,5,8,10,11,12,13 | A | 2,727,929 | 6.12% | 2.06% |
B | 8,168,658 | 93.17% | 61.77% | |
W. Bradford Wiley II2,3,9,10,11,12,13 | A | 2,412,703 | 5.41% | 1.82% |
B | 8,162,256 | 93.09% | 61.72% | |
BlackRock, Inc.14 55 East 52nd Street New York, NY 1005 | A | 6,129,876 | 13.76% | 4.64% |
B | — | — | — | |
Clarkston Capital Partners, LLC15 91 West Long Lake Road Bloomfield Hills, MI 48304 | A | 3,053,500 | 6.85% | 2.31% |
B | — | — | — | |
Neuberger Berman Group LLC16 1290 Avenue of the Americas New York, NY 10104 | A | 2,842,570 | 6.38% | 2.15% |
B | — | — | — | |
The Vanguard Group, Inc.17 100 Vanguard Blvd. Malverne, PA 19355 | A | 5,058,747 | 11.35% | 3.83% |
B | — | — | — | |
86 | ![]() | 2025 Proxy Statement |
Ownership of Common Stock |
2025 Proxy Statement | ![]() | 87 |
Ownership of Common Stock |
88 | ![]() | 2025 Proxy Statement |
2025 Proxy Statement | ![]() | 89 |
Information About the Annual Meeting |
Date and Time | Location | |||||
The 2025 Annual Meeting will be held on Thursday, September 25, 2025, at 8:00 A.M. EDT. | The 2025 Annual Meeting of Shareholders of John Wiley & Sons, Inc. will be held online at www.virtualshareholdermeeting.com/WLY2025 | |||||
![]() | ![]() | ![]() | ![]() | |||
INTERNET | SCAN | PHONE | MAIL | |||
Locate the 16-digit control number included in your proxy card, voting instruction form or notice in order to access the website indicated. | Your proxy card, voting instruction form or notice may also include a QR code for voting by your mobile phone. | You may submit your proxy by touch-tone telephone by dialing the number indicated on your proxy card or voting instruction form. You will need the 16- digit control number shown on your proxy card or voting instruction form. | Mark, sign and date your proxy card or voting instruction form and return it in the postage-paid envelope provided. | |||
90 | ![]() | 2025 Proxy Statement |
Information About the Annual Meeting |
2025 Proxy Statement | ![]() | 91 |
Information About the Annual Meeting |
92 | ![]() | 2025 Proxy Statement |
Information About the Annual Meeting |
2025 Proxy Statement | ![]() | 93 |



